Brief: Newbury Secures Generic Approval For Melatonin Newbury
Aug 11 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST: NEWBURY PHARMACEUTICALS SECURES GENERIC APPROVAL FOR MELATONIN NEWBURY Source text: ID:nMFN9c5CcJ Further company coverage: NEWBRY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln